• US FDA accepts Mylan’s BLA for proposed trastuzumab product pharmaceutical-technology
    January 16, 2017
    Biocon and Mylan have announced acceptance of the latter’s biologics licence application (BLA) by the US Food and Drug Administration (FDA) for MYL-1401O, a proposed biosimilar trastuzumab.
  • Study Casts More Doubt on Value of Mammograms drugs.com
    January 10, 2017
    Mammograms frequently detect small breast tumors that might never become life-threatening, causing women to receive treatment they likely don't need, a new Danish study finds.
PharmaSources Customer Service